The heterogeneous precipitates of A that accumulate in the brain cortex in Alzheimer's disease possess varying degrees of resistance to resolubilization. We previously found that A1-40 is rapidly precipitated in vitro by physiological concentrations of zinc, a neurochemical that is highly abundant in brain compartments where A is most likely to precipitate. We now present evidence that the zinc-induced precipitation of A is mediated by a peptide dimer and favored by conditions that promote ␣-helical and diminish -sheet conformations. The manner in which the synthetic peptide is solubilized was critical to its behavior in vitro. Zincinduced A aggregation was dependent upon the presence of NaCl, was enhanced by ␣-helical-promoting solvents, but was abolished when the peptide stock solution was stored frozen. The A aggregates induced by zinc were reversible by chelation, but could then be reprecipitated by zinc for several cycles, indicating that the peptide's conformation is probably preserved in the zinc-mediated assembly. In contrast, A aggregates induced by low pH (5.5) were not resolubilized by returning the pH milieu to 7.4. The zinc-A interaction exhibits features resembling the gelation process of zinc-mediated fibrin assembly, suggesting that, in events such as clot formation or injury, reversible A assembly could be physiologically purposive. Such a mechanism is contemplated in the early evolution of diffuse plaques in Alzheimer's disease and suggests a possible therapeutic strategy for the resolubilization of some forms of A deposit in the disease.The pathological hallmark of Alzheimer's disease is the abundant accumulation in the brain of A, a 39 -43-amino acid peptide, as morphologically heterogeneous deposits in the neuropil (senile plaques) and cerebral blood vessels (congophilic angiopathy) (1, 2). A is a soluble component of cerebrospinal fluid where it is found in concentrations in the low nanomolar range (3-5). Many studies now indicate that synthetic A becomes toxic to cultured neuronal cells when in a specific -sheet conformation that involves incubating the synthetic peptide in a aqueous solution over time periods of days to weeks (6 -14). Whereas the -sheet conformation of the peptide is found in highly insoluble fibrillar amyloid deposits in Alzheimer's disease, a substantial proportion of A precipitates into nonfibrillar deposits that can be resolubilized by extraction into aqueous solvents (15).We have recently reported that A itself specifically and saturably binds zinc, manifesting high affinity binding (K D ϭ 107 nM) with a 1:1 (zinc:A) stoichiometry and low affinity binding (K D ϭ 5.2 M) with a 2:1 stoichiometry (16). This binding is probably histidine-mediated since it is abolished by acidic pH (no binding at pH 6). The zinc-binding site was mapped to a stretch of contiguous residues between positions 6 -28 of the A sequence. Occupation of the zinc-binding site, which straddles the lysine 16 position of ␣-secretase cleavage (17, 18), inhibits ␣-secretase type (tryp...